CADNX | LANSX | CADNX / LANSX | |
Total Expense Ratio | 0.50 | 0.78 | 64% |
Annual Report Gross Expense Ratio | 0.56 | 0.78 | 72% |
Fund Existence | 11 years | 41 years | - |
Gain YTD | -0.331 | -0.490 | 67% |
Front Load | N/A | 2% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.81B | 4.71B | 38% |
Annual Yield % from dividends | 4.14 | 3.70 | 112% |
Returns for 1 year | 4.30 | 2.91 | 148% |
Returns for 3 years | 4.45 | 3.21 | 139% |
Returns for 5 years | 10.05 | 8.17 | 123% |
Returns for 10 years | 22.17 | 10.79 | 206% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CANC | 23.52 | -0.43 | -1.80% |
Tema Oncology ETF | |||
ADIV | 15.23 | -0.29 | -1.86% |
SmartETFs Asia Pcfc Dvdnd Bldr ETF | |||
PJUN | 36.04 | -1.22 | -3.27% |
Innovator U.S. Equity Power BffrETF™-Jun | |||
BMAR | 44.32 | -1.59 | -3.46% |
Innovator U.S. Equity Buffer ETF™ - Mar | |||
XAR | 156.94 | -7.58 | -4.61% |
SPDR® S&P Aerospace & Defense ETF |